In a study of cDNA microarrays, CD99 emerged as one of the genes differentially expressed between glioblastoma and normal encephalic tissue and was part of a selection of 31 genes encoding membrane proteins that represent potential targets for cellular or antibody-based immunological therapies [19]. The gene discussed is CD99; the disease is glioblastoma.